|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/145 |
| (11) | Number of the document | 2493501 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10768502.6 |
| Date of filing the European patent application | 2010-10-25 | |
| (97) | Date of publication of the European application | 2012-09-05 |
| (45) | Date of publication and mention of the grant of the patent | 2017-04-05 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2010/066083 |
| Date | 2010-10-25 |
| (87) | Number | WO 2011/051235 |
| Date | 2011-05-05 |
| (30) | Number | Date | Country code |
| 0918830 | 2009-10-27 | GB | |
| 329230 P | 2010-04-29 | US |
| (72) |
D` HONDT, Erik Jozef, BE
ENGELMANN, Hans Bernd, DE
|
| (73) |
GlaxoSmithKline Biologicals S.A.,
Rue de l`Institut, 89, 1330 Rixensart,
BE
GlaxoSmithKline Biologicals, Niederlassung der SmithKline Beecham Pharma GmbH & Co. KG, Zirkusstrasse 40, 01069 Dresden, DE |
| (54) | PROCESS FOR PRODUCING INFLUENZA VACCINE |
| PROCESS FOR PRODUCING INFLUENZA VACCINE |